Prevalence of primary immune thrombocytopenia in Oklahoma

被引:69
|
作者
Terrell, Deirdra R. [1 ]
Beebe, Laura A. [1 ]
Neas, Barbara R. [1 ]
Vesely, Sara K. [1 ]
Segal, Jodi B. [2 ]
George, James N. [1 ,3 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73126 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Med, Oklahoma City, OK 73126 USA
关键词
QUALITY-OF-LIFE; PURPURA; ADULTS; CHILDHOOD; CHILDREN; PATIENT;
D O I
10.1002/ajh.23262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the prevalence of immune thrombocytopenia (ITP) in Oklahoma regardless of age, clinical characteristics, insurance status, and source of health care. Patients with ITP were identified by the administrative code ICD-9-CM 287.3 in Oklahoma hematologists' offices for a 2-year period, 20032004. Prevalence was estimated separately for children (<16 years old) and adults because of their distinct clinical characteristics. Oklahoma census data for 2000 was used as the denominator. Eighty-seven (94%) of 93 eligible Oklahoma hematologists participated; 620 patients with ITP were identified. The average annual prevalences were as follows: 8.1 (95% CI: 6.79.5) per 100,000 children, 12.1 (95% CI: 11.113.0) per 100,000 adults, and 11.2 (95% CI: 10.412.0) per 100,000 population. Among children and adults less than age 70 years, the prevalence was greater among women. Among adults aged 70 years and older, the prevalence was greater among men. The highest prevalence of ITP was among men age 80 years and older. These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care. The methodology developed for this prevalence analysis may be adaptable for epidemiologic studies of other uncommon disorders which lack specific diagnostic criteria and are treated primarily by medical specialists. Am. J. Hematol. 2012. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:848 / 852
页数:5
相关论文
共 50 条
  • [31] Romiplostim as early treatment for refractory primary immune thrombocytopenia
    Contis, Anne
    Lazaro, Estibaliz
    Greib, Carine
    Pellegrin, Jean-Luc
    Viallard, Jean-Francois
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (05) : 520 - 524
  • [32] Management of Primary Immune Thrombocytopenia in Pregnancy
    Bussel, James B.
    Hou, Ming
    Cines, Douglas B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (06): : 540 - 548
  • [33] Treatments for Primary Immune Thrombocytopenia: A Review
    Samson, Margot
    Fraser, William
    Lebowitz, David
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (10)
  • [34] Lymphocyte subsets in primary immune thrombocytopenia
    Wei Rong
    Zhang Yan-xiang
    Xu Shan-shan
    Shi Ju-mei
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (08) : 816 - 819
  • [35] Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry
    Arnold, Donald M.
    Nazy, Ishac
    Clare, Rumi
    Jaffer, Anushka M.
    Aubie, Brandon
    Li, Na
    Kelton, John G.
    BLOOD ADVANCES, 2017, 1 (25) : 2414 - 2420
  • [36] EFFICACY OF SPLENECTOMY IN PRIMARY IMMUNE THROMBOCYTOPENIA
    Soboleva, O. A.
    Egorova, E. K.
    Pustovaya, E., I
    Sorkina, O. M.
    Sabirov, K. R.
    Gemdzhian, E. G.
    Prasolov, N., V
    Danishyan, K., I
    Melikyan, A. L.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (03): : 362 - 373
  • [37] Advances in the pathophysiology of primary immune thrombocytopenia
    Perera, Maria
    Garrido, Teresa
    HEMATOLOGY, 2017, 22 (01) : 41 - 53
  • [38] Current treatment of primary immune thrombocytopenia
    Lozano, Maria L.
    Vicente, Vicente
    MEDICINA CLINICA, 2014, 142 (09): : 399 - 405
  • [39] Immune thrombocytopenia in infants: a retrospective study with comparison to toddlers
    Lee, Anselm Chi-wai
    SINGAPORE MEDICAL JOURNAL, 2025, 66 (01) : 20 - 23
  • [40] Treatment options in immune thrombocytopenia
    Dubis, Laura
    Collins, Miranda
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2016, 29 (12): : 59 - 63